Lamisil DermGel

Lamisil DermGel Dosage/Direction for Use

terbinafine

Manufacturer:

GlaxoSmithKline Consumer

Distributor:

DKSH
Full Prescribing Info
Dosage/Direction for Use
For cutaneous use only.
Elderly: There is no evidence to suggest that elderly patients require different dosages or experience side effects different to those in younger patients.
Adults and adolescent aged 12 years and over: Duration and frequency of treatment: Interdigital type tinea pedis: Once a day for one week.
Tinea corporis, tinea cruris: Once a day for one week.
Pityriasis versicolor: Once or twice a day for one week.
Clinical symptoms usually start to improve within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence.
If there are no signs of improvement within 2 weeks of first starting treatment, patients should see a doctor or pharmacist to verify diagnosis.
Method of administration: Before first use, the sealing membrane of the tube must be pierced using the point incorporated into the screw cap.
The affected area should be cleaned and dried thoroughly before application. The gel should be applied to the affected skin and surrounding area in a thin layer and rubbed it lightly. In the case of intertriginous infections (submammary, interdigital, intergluteal, inguinal), the application may be covered with a gauze, especially at night.
Children: Not recommended for use in children below 12 years of age due to insufficient data on safety and efficacy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in